Inspection of Etomidate Following Its Designation as a Narcotic

Inspection Completed at 77 Medical Institutions Across 23 Districts

Verification of Storage, Inventory Management, and Handling Reports

The Seoul Metropolitan Government has conducted an intensive inspection of medical institutions for narcotics management and detected 15 facilities in violation of regulations.


According to the city on June 23, this investigation was carried out jointly with district offices, targeting 77 medical institutions that handle etomidate. Etomidate is a drug used for the induction of general anesthesia and, starting this year, has been designated and managed as a psychotropic drug under the Narcotics Control Act. Due to ongoing concerns about its illegal use as a substitute for propofol and the persistent risk of misuse and abuse, regulatory oversight has been strengthened.

Narcotics Storage Facility. Seoul City

Narcotics Storage Facility. Seoul City

View original image

Notably, the driver involved in the so-called "Lamborghini incident"—a case that drew public controversy in 2023 for wielding a weapon during a parking dispute—was also found to have administered etomidate. More recently, there have even been cases of "Zombie Cigarettes," where etomidate is mixed with electronic cigarette liquids, further raising public awareness and concern.


More than 50 personnel from the Seoul city government and district offices participated in the inspection, forming two-person teams that conducted inspections over the course of one month starting from May 20. The city selected 77 medical institutions that either had a record of etomidate supply or had registered inventory in the Narcotics Integrated Management System (NIMS) for on-site inspections. The main inspection points included: ▲compliance with narcotics storage standards; ▲consistency between actual inventory and inventory registered in the NIMS; ▲proper storage of expired narcotics; and ▲appropriate reporting of narcotics handling records, among others.


The inspection revealed 18 violations of the Narcotics Control Act at 15 medical institutions. The city plans to impose administrative measures in accordance with relevant laws, such as warnings, fines, and suspension of narcotics-related work, while also pursuing prosecution depending on the severity of the violation. The types of violations were as follows: ▲1 case of inventory discrepancy; ▲4 cases of improper maintenance of the storage facility inspection log; and ▲13 cases of violations in narcotics handling reporting. Accordingly, the city plans to issue warnings to 11 institutions, suspend narcotics handling work at 5 institutions, impose fines at 1 institution, and file charges against 2 institutions.


The Seoul Metropolitan Government intends to strengthen its management system for medical narcotics based on the findings of this inspection. In the second half of the year, the city will conduct intensive inspections of medical institutions that handle propofol, which is of high concern for abuse and misuse, to prevent illegal distribution and improper use, and to strengthen the responsibility of medical institutions for proper management.


Since 2023, Seoul has operated a "Narcotics Response Team," the first of its kind in Korea, to address the growing illegal distribution of narcotics and the misuse of medical narcotics. Under the recognition that drug abuse is a societal issue rather than merely an individual's deviation, the city is building an integrated response system covering prevention, treatment, and rehabilitation.



Cho Youngchang, Director of the Seoul Metropolitan Government's Citizens' Health Bureau, stated, "If medical narcotics are not properly managed, they can lead to serious issues such as illegal distribution and abuse, making responsible management by medical institutions more important than ever. The city will continue to monitor narcotics management at medical institutions to reduce public anxiety and ensure a safe medical environment."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing